Compounds > ym 09151-2
Page last updated: 2024-09-04

ym 09151-2 and oxidopamine

ym 09151-2 has been researched along with oxidopamine in 4 studies

Compound Research Comparison

Studies
(ym 09151-2)		Trials
(ym 09151-2)		Recent Studies (post-2010)
(ym 09151-2)		Studies
(oxidopamine)		Trials
(oxidopamine)		Recent Studies (post-2010) (oxidopamine)
2496138,63062,407

Protein Interaction Comparison

ProteinTaxonomyym 09151-2 (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walters, JR; Weick, BG1
Okamura, H; Yokoyama, C1
Araki, T; Itoyama, Y; Kato, H; Tanji, H1
Dewar, KM; Elie, R; Vasiliadis, HM1

Other Studies

4 other study(ies) available for ym 09151-2 and oxidopamine

ArticleYear
Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Brain research, 1987, Mar-10, Volume: 405, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Apomorphine; Benzamides; Benzazepines; Dopamine; Dopamine Antagonists; Drug Interactions; Ergolines; Hydroxydopamines; Male; Oxidopamine; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra; Time Factors

1987
Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:2

    Topics: Animals; Animals, Newborn; Autoradiography; Benzamides; Benzazepines; Brain; Cerebral Cortex; Corpus Striatum; Dopamine; Dopamine Antagonists; Female; Hypothalamus; Nerve Fibers; Neurons; Organ Specificity; Oxidopamine; Pregnancy; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Reference Values; Self Mutilation; Substantia Nigra; Tritium; Tyrosine 3-Monooxygenase; Up-Regulation

1997
Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
    Journal of the neurological sciences, 1998, Oct-08, Volume: 160, Issue:2

    Topics: Adrenergic Agents; Animals; Autoradiography; Benzamides; Benzazepines; Brain Diseases; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Male; Mazindol; Medial Forebrain Bundle; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors

1998
Interaction between dopamine and glutamate receptors following treatment with NMDA receptor antagonists.
    European journal of pharmacology, 1999, Dec-15, Volume: 386, Issue:2-3

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzamides; Benzazepines; Dizocilpine Maleate; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Female; Oxidopamine; Piperazines; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptors, AMPA; Receptors, Dopamine; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Tritium

1999